title: Anthelmintics for cattle.
abstract: A number of anthelmintics are available for the control of gastrointestinal nematodes in cattle. In North America, O. ostertagi, Cooperia spp., lung worm, and F. hepatica probably cause the greatest losses in production. The older anthelmintics are often deficient in their action against some of these parasites. Recently, the Paratect morantel tartrate slow-release bolus has provided a mechanism for the prevention of infections with gastrointestinal nematodes and lung worm, to some extent, and this has been shown to produce considerable economic benefits. Fenbendazole removes arrested O. ostertagi larvae; thus, its availability is an important step in the prevention of type-2 ostertagiasis. It also has a very broad spectrum of activity that includes most other nematodes and tapeworms and is a very safe anthelmintic. Ivermectin is highly effective against almost all cattle nematodes and also has great value for the control of arthropod ectoparasites. In addition, it and levamisole are the only anti-nematode drugs that can be administered to cattle by injection. Clorsulon is a new, safe anthelmintic that provides good control of liver fluke and, thus, fills a gap in the control of helminths of cattle in North America. The efficient use of anthelmintics in association with management based on a knowledge of parasite epidemiology can ensure that cattle do not rapidly become re-infected. In this way, the benefits from the use of anthelmintics can be very considerable and far greater than the costs of control.
mesh_terms: D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy*; D003372:Coumaphos / Q000627:therapeutic use; D005273:Fenbendazole / Q000627:therapeutic use; D006373:Helminthiasis / Q000188:drug therapy; D006374:Helminthiasis, Animal; D007559:Ivermectin; D007700:Kinetics; D007783:Lactones / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D009015:Morantel / Q000627:therapeutic use; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D010640:Phenothiazines / Q000627:therapeutic use; D013424:Sulfanilamides / Q000627:therapeutic use; D013827:Thiabendazole / Q000627:therapeutic use; D014468:Umbelliferones / Q000627:therapeutic use
chemical_list: D000871:Anthelmintics; D001562:Benzimidazoles; D007783:Lactones; D009943:Organophosphorus Compounds; D010640:Phenothiazines; D013424:Sulfanilamides; D014468:Umbelliferones; D007978:Levamisole; D005273:Fenbendazole; D007559:Ivermectin; D009015:Morantel; C015675:clorsulon; D003372:Coumaphos; D013827:Thiabendazole; C007902:haloxon